Hospital

Pharmacy leaders navigate complex compliance challenges, budget constraints, and evolving technology to enhance safety and efficiency in compounding practices.

IV compounding robotics enhance safety, reduce drug shortages, and improve efficiency in hospital pharmacies, driving a shift towards automation.

Exploratory analysis shows 1 in 4 patients maintain long-term response to ribociclib.

Pharmacists leverage sodium-glucose cotransporter 2 (SGLT2) inhibitors to improve interconnected cardiovascular-kidney-metabolic (CKM) syndrome outcomes through holistic, patient-centered care.

Economic factors are driving sterile injectable drug shortages, but collaborative strategies can enhance health care industry resiliency.

Pharmacists can enhance patient care through integrated treatment strategies.

Specialty pharmacy services are helping improve IBD care by supporting patient education, access, and confidence in biosimilars

Pharmacists play a vital role in preventing maternal and neonatal mortality by understanding pregnancy-specific medication needs and emergency care strategies.

Rural hospitals face a crisis, but pharmacists can expand services to alleviate the uninsured patient burden and enhance community health.

Pharmacists can contribute to the care of patients with multiple myeloma by managing cytokine release syndrome and encouraging vaccination when receiving anti-CD38 antibody treatment.

Key takeaways about unit-based pharmacy models for pharmacists and institutions.

Discover how the combination of palbociclib, trastuzumab, and endocrine therapy enhances survival in HER2-positive advanced breast cancer patients.

Shivang Joshi, MD, MPH, RPh, FAHS, highlights Symbravo’s non-substitutability, multi-mechanistic design, and key safety considerations for pharmacists across care settings.

Expert pharmacists discuss future outlooks for unit-based pharmacy models.

MRD and ctDNA testing could revolutionize monitoring and diagnosing precursor diseases of multiple myeloma.

Pharmacists discuss educational opportunities and training opportunities for pharmacists interested in unit-based pharmacy models.

Emerging pharmacy trends will be highlighted at the American Society of Health-System Pharmacists (ASHP) Midyear 2025, including AI innovations, GLP-1 therapies, and evolving geriatric and neonatal care.

Shivang Joshi, MD, MPH, RPh, FAHS, outlines essential counseling points on dosing, timing, contraindications, and rebound headache risks when dispensing Symbravo.

Unit-based pharmacists discuss their crucial roles in advancing interdisciplinary care.

Pirtobrutinib’s indication was expanded for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, allowing for treatment in earlier lines of therapy.

The supplemental new drug application (sNDA) was assigned a PDUFA target action date of July 26, 2026.

Pharmacists can help close the lung cancer screening gap by identifying high-risk tobacco users, increasing awareness, and connecting eligible patients to lifesaving early detection.

Unit-based pharmacists discuss the key contributions they make to the care team.

A panel of pharmacists discuss the innerworkings of unit-based pharmacy.

A cohort study of over 6 million US veterans revealed a 76% increased risk of pancreatic cancer following chronic hepatitis C infection.